# Emcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing.

*biotech · news · 2026-05-05 · The Economic Times*

## Key points

- Emcure Pharmaceuticals is actively seeking both domestic and international acquisitions for expansion.
- The Novo Nordisk partnership allows Emcure to distribute semaglutide under the Poviztra brand.
- New product launches are projected to contribute early-to-mid-teens percentage to growth in five years.
- Emcure is strategically focusing on complex injectables and biosimilars, citing significant untapped potential.

**Companies:** Emcure Pharmaceuticals
**Countries:** India, Denmark

[Read the full story on The Economic Times](https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/emcure-eyes-india-growth-global-deals-amid-strong-demand/articleshow/130835345.cms)

---

Canonical: https://newsio.io/n/b81d9e18-37e2-4f50-9618-e9de9eaee614/emcure-pharmaceuticals-is-boosting-domestic-expansion-rd-and-manufacturing-the-c
Summarized by Newsio from The Economic Times. https://newsio.io/how-it-works